Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesVascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinIron overload diminishes atherosclerosis in apoE-deficient miceIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesPromotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles.Atherogenesis and iron: from epidemiology to cellular level.The iron hypothesis:does iron play a role in atherosclerosis?Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.Targeting heme oxygenase-1 in vascular diseaseThe atherogenic effect of excess methionine intakeIron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental miceA novel model for IFN-γ-mediated autoinflammatory syndromes.Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light.Iron, inflammation and atherosclerosis risk in men vs. perimenopausal women.Iron and thrombosisCan iron chelators influence the progression of atherosclerosis?Testing the iron hypothesis in a mouse model of atherosclerosis.In search of antioxidants and anti-atherosclerotic agents from herbal medicines.Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection.Iron as a target of chemoprevention for longevity in humans.Diet and atherosclerosis in apolipoprotein E-deficient mice.Iron deficiency anemia in heart failure.Molecular biology of atherosclerosis.Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration.Heme Oxygenases in Cardiovascular Health and Disease.Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.Iron and cardiac ischemia: a natural, quasi-random experiment comparing eligible with disqualified blood donors.Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice.Deferoxamine-fibrin accelerates angiogenesis in a rabbit model of peripheral ischemia.Secretion of ferritin by iron-laden macrophages and influence of lipoproteins.Iron management in hemodialysis patients: optimizing outcomes in Vicenza, Italy.Elevated oxidative stress, iron accumulation around microvessels and increased 4-hydroxynonenal immunostaining in zone 1 of the liver acinus in hypercholesterolemic rabbits.Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques.The effect of iron status on vascular health.Relationship between body iron stores and diquat toxicity in male Fischer-344 rats.Sulfur amino acids and atherosclerosis: a role for excess dietary methionine.Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice.
P2860
Q24289511-67143AB7-6D24-4F7A-804B-3B249203AE1BQ26750865-F3765DC5-2C36-4191-A736-33CB56863EB4Q28367084-D1AC0974-BB26-4F91-B70D-A7E7E68ABF69Q28388335-3D12D590-DF86-4F95-96B3-81D952C871D8Q33572498-BB4FA1E0-B5F0-4139-9157-F2A2306C71F9Q33595279-318DC5D1-DA43-44E6-83F8-B7FD100EC230Q34014713-50C469A7-25D2-4EA4-9995-725D5C2E0AF5Q34064046-A35CDCE2-8065-4D22-9D2C-762BF9C58E37Q34299531-C9A1FD58-96DB-44CA-9016-879A1E40AFF2Q34390949-05DDDC05-8F5F-4417-A752-79016C37E359Q34427619-CAF6F177-94CD-4035-AD5C-C7CD554659BDQ34506972-A394CBBB-88A5-414F-B729-5894DC692607Q34671352-AA7B7AA8-B25C-4045-8546-E6962D43B013Q35110844-1297DA11-4A51-4C84-BF92-9DC5378A7674Q35677941-85F5C728-4344-4977-BEA2-4BDCB589B568Q36051853-5B5B7A5F-88C6-4B7D-AD4D-7D0B50CC5C49Q36428416-C062993F-D390-4F3F-BF1F-2ED8E92FCE5AQ37084727-7BC878AA-E221-440C-85AF-6948D9BD7E8EQ37430727-EB8639F0-A21D-417B-AD8F-5E87C58F72F4Q37586734-E1AC7C42-A15B-4ECB-8B65-009C3FD4022EQ37861473-4FA3DFA3-48DC-48F7-819B-3E39FA0D16D9Q37880111-C9440EA1-0F33-4486-B69D-590248073E2BQ37889038-9D525689-8DB6-4D35-8A7F-2E98A98F380FQ38040656-12E4E781-AADE-485B-9D88-342359BD45F0Q38125279-07211CD2-C35E-4E38-A5BB-F336E468866CQ38161837-9EE2E12E-88DC-42BA-BA72-3E5E2A0343B7Q38823562-9AF442AD-61C1-4EDA-8234-F8B9BB836725Q40646574-C941C7F6-5091-4675-8E76-1373C80D227EQ43415845-FF283417-FC5D-4A1D-A0A3-BD046250EA3BQ44556133-8B59CB44-2196-478B-838C-2B47655A1493Q44780004-D3CFAB69-2304-4E7A-B35A-808C224A01FBQ45129263-0217BD1F-A63C-43A1-8068-4A96C7DF3636Q46044386-E22A318F-98E9-478A-A3CC-A8914A7C15D7Q46137845-845B9FBE-CB20-47C6-B107-AA28B37A2324Q46619854-D239EFFE-1F4A-406C-B6F2-8199F1064193Q47849733-5BECCFC1-AD4C-4B63-87F6-3DB4680948B5Q50735746-56EB87C0-3F74-4B05-8DFE-F42603D86825Q52145156-A4CAE37E-AD59-436F-B394-719915932AC7Q53611817-B023BC7D-9B25-4E45-AE5D-F877CBFFB255
P2860
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@en
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@nl
type
label
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@en
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@nl
prefLabel
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@en
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@nl
P2093
P356
P1433
P1476
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
@en
P2093
P304
P356
10.1161/01.CIR.99.9.1222
P407
P577
1999-03-01T00:00:00Z